Vascular and lymphatic malformations of the gastrointestinal tract represent uncommon diagnostic challenges for clinicians worldwide. Among these lesions, an intestinal lymphangioma is an exceptionally rare benign neoplasm that originates from sequestered lymphatic sacs. While primary intestinal lymphangiectasia classically manifests with protein-losing enteropathy, secondary dilation of mucosal and submucosal lacteals can arise due to localized structural obstruction. Adult patients rarely present with life-threatening gastrointestinal hemorrhage from these anomalies. Consequently, diagnosis often requires high clinical vigilance and sophisticated endoscopic techniques. When severe diffuse lesions resist conventional hemostatic and medical therapies, management becomes particularly complex. This article reviews a landmark clinical case where adult-onset disease prompted emergency intervention and intestinal transplantation.

Understanding Intestinal Lymphangioma and Lymphangiectasia

Benign vascular tumors of the digestive tract comprise less than two percent of all small intestinal neoplasms. In particular, an intestinal lymphangioma consists of abnormal lymphatic channel proliferation within the submucosa and muscularis layers. Clinicians frequently encounter congenital lymphatic anomalies during early pediatric years. However, adult presentations remain exceedingly uncommon and usually follow an indolent, asymptomatic trajectory. Secondary intestinal lymphangiectasia develops when proximal mesenteric or retroperitoneal lymphatic flow suffers progressive mechanical occlusion, leading to elevated intraluminal lymphatic pressure. Therefore, delicate mucosal lacteals become markedly engorged throughout the intestinal villi. These dilated channels can spontaneously rupture, which typically produces profound protein wasting, hypoproteinemia, and marked lymphopenia. In rare circumstances, chronic lymphatic hypertension creates direct vascular communication or mucosal erosion that precipitates severe enteric bleeding rather than classic chylous ascites. Because intestinal lymphangiomas often present diffusely or multifocally, pinpointing the precise hemorrhagic origin requires advanced endoscopic modalities. Understanding this atypical pathomechanics is essential for emergency clinicians, gastroenterologists, and surgical teams encountering obscure gastrointestinal blood loss. Early clinical recognition prevents catastrophic diagnostic delays. Furthermore, distinguishing secondary lymphangiectasia from primary malformations ensures that clinicians evaluate patients thoroughly for hidden obstructive mesenteric lesions.

Clinical Presentation: Refractory Bleeding Without Protein Loss

In a recently documented sentinel case, a 40-year-old male presented with severe recurrent gastrointestinal hemorrhage and symptomatic iron-deficiency anemia. The patient experienced repeated episodes of melena and hemodynamic compromise that rapidly exhausted outpatient management. Interestingly, the patient exhibited neither peripheral edema nor chronic diarrhea, which typically dominate primary mucosal lymphatic disorders. Laboratory investigations showed profound microcytic hypochromic anemia without significant hypogammaglobulinemia or marked hypoalbuminemia. Furthermore, extensive medical therapy, dietary fat restriction, and supportive measures failed to curb the unrelenting blood loss. The patient rapidly developed transfusion dependency, eventually requiring more than twenty units of packed red blood cells over a brief hospitalization period. This aggressive clinical trajectory highlighted the catastrophic potential of vascular disruption within the mesenteric lymphatic bed. Consequently, treating clinicians had to expedite invasive endoscopic and angiographic evaluations to pinpoint the hemorrhaging focus before lethal exsanguination occurred. Adult-onset presentations with life-threatening hemorrhage represent an exceptional clinical departure from standard textbook descriptions of lymphatic disease. Therefore, clinicians must maintain high suspicion even when hallmark metabolic features of protein wasting remain entirely absent.

Diagnostic Workup: Endoscopy and Advanced Imaging Modalities

Accurately localizing small bowel bleeding remains one of the most demanding tasks in gastrointestinal medicine. In this complex case, double-balloon enteroscopy provided vital visual evidence of diffuse mucosal pathology. The endoscopists observed extensive jejunal infiltration characterized by prominent, diffuse white villi, which indicated marked lymphatic ectasia. In addition, abdominal computed tomography identified prominent mesenteric lymphadenopathy alongside focal small bowel mural thickening. Because dynamic bleeding persisted despite aggressive stabilization attempts, nuclear medicine physicians performed technetium-99m-labeled red blood cell scintigraphy. The scintigraphy scan revealed active extraluminal tracer pooling within the superior mesenteric artery vascular distribution. Moreover, catheter angiography confirmed abnormal vascular blushes, although interventional radiologic embolization could not safely arrest the diffuse multi-segment bleeding. Therefore, cross-sectional imaging and deep enteroscopy served complementary roles in defining the disease boundaries. These multimodal findings successfully ruled out focal peptic ulcers and directed the clinical team toward definitive surgical resection. Without deep enteroscopic exploration, such extensive proximal jejunal vascular malformations often escape routine upper and lower endoscopies. Consequently, modern device-assisted enteroscopy remains indispensable for mapping extensive lymphatic anomalies across deep jejunal and ileal loops.

Pathological Findings and Differential Diagnosis

Histopathological examination of surgical biopsy specimens remains the definitive gold standard for categorizing complex intestinal lymphatic disorders. In the reported patient, tissue biopsies confirmed the diagnosis of intestinal lymphangioma with extensive secondary lymphangiectasia. Pathologists observed vastly expanded lymphatic channels lined by bland, CD31-positive and D2-40-positive endothelial cells throughout the mucosa and submucosa. Moreover, the resected specimen revealed that lymphatic ectasia extended beyond the small intestine into the colon, appendix, and gallbladder. This widespread multi-organ involvement demonstrated the aggressive anatomic footprint of the vascular anomaly. Importantly, histopathologists thoroughly examined all harvested mesenteric lymph nodes, which exhibited only reactive hyperplasia. This crucial finding excluded malignant lymphoproliferative disorders, neuroendocrine tumors, and systemic amyloidosis from the differential diagnosis. In addition, special stains ruled out mycobacterial infections and Whipple disease, which can induce secondary mesenteric obstruction. Thus, the pathological evaluation confirmed a benign yet anatomically devastating lymphatic disease that caused massive structural destruction of the mucosal microvasculature. Consequently, comprehensive pathological sampling of resected margins and regional lymph nodes proves vital to distinguish reactive lymphatic ectasia from invasive neoplastic malignancies.

Surgical Intervention: Rationale for Small Bowel Transplantation

When conservative management and endoscopic therapies fail to control massive small bowel hemorrhage, radical surgery becomes inevitable. Segmental resection typically provides definitive treatment for solitary intestinal tumors. However, in this patient, the lymphatic dilation involved nearly the entire jejunum, ileum, and adjacent colonic segments. As a result, segmental resection was anatomically impossible without creating instantaneous, fatal short bowel syndrome. Facing refractory hemorrhagic shock and continuous transfusion requirements, the multidisciplinary surgical team made the decision to perform an emergency small bowel transplantation accompanied by subtotal colectomy. Intestinal transplantation is traditionally reserved for irreversible intestinal failure, severe total parenteral nutrition complications, or unmanageable intra-abdominal desmoid tumors. In this extraordinary scenario, transplantation represented the sole life-saving salvage strategy available to eliminate the diffuse hemorrhaging substrate. Consequently, the surgical team removed the diseased visceral organs and successfully engrafted the intestinal donor graft. Although high-risk, this aggressive surgical intervention provided the only physical barrier against imminent exsanguination from diffuse enteric bleeding. Therefore, intestinal transplantation must enter multidisciplinary discussions when pan-enteric vascular lesions cause life-threatening bleeding refractory to standard operative resections.

Postoperative Complications and Critical Care Considerations

Postoperative management following multi-visceral and small bowel transplantation presents formidable clinical hurdles, particularly after emergency operations. Following the transplant procedure, the patient required aggressive immunosuppression and intensive care support. However, prolonged hemorrhagic shock and massive transfusion protocols severely compromised the patient’s systemic physiological reserve. Consequently, the patient developed catastrophic postoperative complications, including extensive deep venous thrombosis and severe empyema. Furthermore, systemic inflammatory response syndrome rapidly transitioned into refractory multiorgan dysfunction syndrome. Despite invasive mechanical ventilation, continuous renal replacement therapy, and broad-spectrum antimicrobial coverage, the patient unfortunately succumbed to multiorgan failure on postoperative day twenty. This tragic outcome underscores the profound physiological toll of delayed intervention in catastrophic gastrointestinal bleeding. Additionally, it illustrates the critical need for early multidisciplinary consensus when managing refractory, non-malignant enteric vascular disorders. Managing critical allograft recipients demands vigilant hemodynamic monitoring and aggressive prophylaxis against thromboembolic and infectious insults. Clinicians must recognize that severe preoperative anemia and coagulopathy drastically elevate post-transplant morbidity. Thus, proactive stabilization remains essential before attempting radical intestinal salvage procedures in critically ill patients.

Frequently Asked Questions

How does intestinal lymphangioma cause severe gastrointestinal bleeding?

Intestinal lymphangioma creates abnormal lymphatic channels that distort adjacent capillary beds. Chronic lymphatic hypertension causes these fragile channels to engorge, erode through the mucosal epithelium, and rupture. In severe situations, high intraluminal pressure fosters direct microscopic fistulization between dilated mucosal lacteals and enteric arterioles. Consequently, patients experience massive intraluminal blood loss and severe refractory iron-deficiency anemia rather than indolent chylous effusion or protein leakage.

Why is protein-losing enteropathy sometimes absent in intestinal lymphangiectasia?

Protein-losing enteropathy typically manifests when widespread mucosal rupture allows large amounts of serum proteins and lymphocytes to leak into the bowel lumen. However, if structural lymphatic malformations cause early vascular erosion or thrombosis, localized enteric hemorrhage may precede diffuse protein wasting. In addition, rapid blood replacement and preserved hepatic albumin synthesis can temporarily mask subtle serum albumin reductions during acute bleeding presentations.

When should small bowel transplantation be considered for intestinal vascular lesions?

Transplantation serves as an extreme salvage therapy when diffuse intestinal vascular malformations cause uncontrollable, life-threatening hemorrhage across extensive bowel segments. When curative segmental resection would cause fatal ultra-short bowel syndrome and endovascular embolization fails, organ replacement remains the only viable option. However, high surgical morbidity and severe post-transplant complications necessitate rigorous patient selection, ethical consideration, and urgent multidisciplinary coordination across specialized transplant teams.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Moghadaam NS et al. Intestinal Lymphangioma With Extensive Secondary Lymphangiectasia Causing Life-Threatening Hemorrhage: First Case Requiring Small Bowel Transplantation. Case Rep Pathol. 2026 undefined undefined. doi: 10.1155/crip/6663208. PMID: 42732416.
2. Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J Rare Dis. 2008;3:5. doi: 10.1186/1750-1172-3-5.
3. Al-Dahan S, Lee K, Patel R. Intestinal Lymphangioma Presenting With Small Bowel Bleeding: A Diagnostic Dilemma. Cureus. 2025;17(6):e63198. doi: 10.7759/cureus.63198.
4. Freeman HJ, Nimmo M. Intestinal lymphangiectasia in adults. World J Gastrointest Oncol. 2011;3(2):19-23. doi: 10.4251/wjgo.v3.i2.19.